Search for: "Myers v. Pfizer, Inc." Results 41 - 60 of 71
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Oct 2010, 8:43 am by Peter Rost
Rost and Maria Bartiromo:PHARMACEUTICAL EXECUTIVEClick on images to read.BRANDWEEK Click on images to read.FORTUNE Click on images to read.Click on images to read: THE DAY: "PFIZER WHISTLEBLOWER IN RUNNING FOR TOP FDA POST" Former Pfizer VP Rost finds support for jobBy Lee HowardPublished on 12/6/2008The Day, CTIf Pfizer Inc. were to describe its worst nightmare, it might very well be seeing former company whistleblower Peter Rost become commissioner of… [read post]
18 Aug 2010, 12:19 am by Kelly
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
24 Mar 2010, 4:45 am
INPI (EPLAW) Lyrica (Pregabalin) – US: Patent infringement complaint filed following a Para IV certification: Pfizer Inc. et al. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
9 Dec 2009, 3:59 pm
Immunocorp (PATracer) Lipitor (Atorvastatin) – US: Complaint filed in Delaware - Infringement of US patent following Paragraph IV challenge: Pfizer Inc. et al. v. [read post]
28 Sep 2009, 1:31 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]
28 Sep 2009, 1:31 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]
28 Sep 2009, 1:31 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]
24 Sep 2009, 5:09 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog)   General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court… [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
5 May 2009, 5:57 am
The cases, both on alleged failure to warn of the risk of suicide, include one against Glaxo over Paxil and one against New York-based Pfizer Inc. over Zoloft. [read post]